Oligonucleotide Manufacturing CDMOs in Europe
9 published
9 published CDMOs match Oligonucleotide Manufacturing in Europe.
Locations in this set include United States, United Kingdom, Singapore, Switzerland, China, and Germany.
Capabilities that show up most often in this set: Oligonucleotide, Peptide, Biologics (Other), Small Molecule, and Microbiome Therapeutic.
Matching companies
AXOlabsIntegrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany.
Almac GroupGlobal CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities.- Asymchem LaboratoriesAsymchem is a CDMO providing integrated API synthesis, drug product development, and biologics manufacturing with specialized capabilities in peptides, oligonucleotides, highly potent compounds, and flow chemistry.
BachemGlobal leader in peptide and oligonucleotide development and manufacturing, offering GMP-compliant clinical and commercial supply from early research through commercial scale.
Ella BiotechIndependent German custom oligonucleotide synthesis provider near Munich, serving research, diagnostics, and preclinical development. Offers siRNA, ASO gapmer, and TRImer oligos with HPLC and mass spectrometry QC under ISO 9001 and ISO 13485 certification.
Global Biotech LaboratoriesGlobal Biotech Laboratories is a peptide and oligonucleotide CDMO offering end-to-end contract development and manufacturing from route scouting through validated commercial supply, with cGMP and ICH Q7 compliance across manufacturing sites on three continents.
HitGen Inc.HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Sophia CDMOEuropean CDMO specializing in microbial and precision fermentation up to 40,000 L across two integrated sites (Pamplona, Spain and Basel, Switzerland), with core strengths in E. coli expression, animal health biologics, probiotics, and complex CMC programs requiring scale-up discipline and impurity control.
Markdown mirror: /services/oligonucleotide-manufacturing/europe.md